KORRO BIO INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$14.32
+0.81%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
+47.4%
3 months
+33.3%
6 months
+5.5%
1 year
-60.7%
Year to date
+78.7%
52-week range
$5.28 – $40.91
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$210.8M
P/E
-2
P/B
2
P/S
88.5
Revenue
$2.38M
Net income
-$106.64M
Diluted EPS
-10
Gross margin
100.00%
Net margin
-4477.10%
Return on equity
-114.30%
Total debt
$42.21M
Cash
$24.91M
Free cash flow
-$68.27M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $0 | -$18.92M | — | — | -$17.03M |
| Mar 31, 2026 | $0 | -$19.63M | — | — | -$16.1M |
| Dec 31, 2025 | $1.29M | -$50.04M | 100.00% | -3873.20% | -$17.79M |
| Sep 30, 2025 | $1.09M | -$18.06M | 100.00% | -1657.00% | -$17.35M |
| Jun 30, 2025 | $1.46M | -$25.77M | 100.00% | -1765.10% | -$19.37M |
| Mar 31, 2025 | $2.55M | -$23.39M | 100.00% | -917.10% | -$24.57M |
| Dec 31, 2024 | $2.27M | -$21.2M | 100.00% | -933.50% | -$8.95M |
| Sep 30, 2024 | $0 | -$21M | — | — | -$20.97M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent KRRO news
All market newsNo ticker-linked stories are in the current archive.